BioNTech SE (BNTX) EPS (Basic) (QoQ) (2018 - 2025)
BioNTech SE (BNTX) EPS (Basic) (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | BioNTech SE | 23.54 Bn | 5.15 Bn | 668.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -290.98% |
| Sep 30, 2025 | 119.26% |
| Jun 30, 2025 | 5.12% |
| Mar 31, 2025 | -236.36% |
| Dec 31, 2024 | 179.91% |
| Sep 30, 2024 | 115.14% |
| Jun 30, 2024 | -128.63% |
| Mar 31, 2024 | -140.52% |
| Dec 31, 2023 | 195.05% |
| Sep 30, 2023 | 146.39% |
| Jun 30, 2023 | -170.43% |
| Mar 31, 2023 | -76.37% |
| Dec 31, 2022 | 32.98% |
| Sep 30, 2022 | -1.15% |
| Jun 30, 2022 | -55.49% |
| Mar 31, 2022 | 196,372,701.94% |
| Dec 31, 2021 | -100.00% |
| Sep 30, 2021 | 14.04% |
| Jun 30, 2021 | 143.44% |
| Mar 31, 2021 | 594,637,312.32% |